Fraction Surviving First-Pass Effect Calculator
Estimate how much oral dose survives gut and hepatic first-pass metabolism and reaches systemic circulation.
How to Calculate the Fraction of Drug Surviving First-Pass Effect
The first-pass effect is one of the most important concepts in clinical pharmacokinetics, especially when you are working with oral dosing. Many learners hear that oral drugs are reduced by metabolism before they enter the bloodstream, but they are not always shown a practical method to calculate exactly how much drug survives this process. This guide gives you the full framework used in pharmacology and translational drug development, with a calculator you can use immediately.
In simple terms, the first-pass effect is presystemic elimination that occurs before a drug reaches systemic circulation. For most oral drugs, this involves intestinal metabolism, transport related losses in the gut wall, and metabolism in the liver after portal venous delivery. The quantity that survives this route strongly influences oral bioavailability, onset of action, dose selection, and variability between patients.
Core Equation You Need
The standard oral bioavailability framework is:
F = Fa x Fg x Fh
- Fa is the fraction absorbed from the gastrointestinal lumen into enterocytes.
- Fg is the fraction escaping intestinal first-pass extraction.
- Fh is the fraction escaping hepatic first-pass extraction.
If you are specifically asked for the fraction surviving first-pass metabolism, and Fa is already known or assumed complete, then the first-pass survival term is:
First-pass survival fraction = Fg x Fh = (1 – Eg) x (1 – Eh)
where Eg and Eh are extraction ratios in gut and liver. If Fa is included, the total fraction reaching systemic circulation from an oral dose is:
Systemic fraction from oral dose = Fa x (1 – Eg) x (1 – Eh)
Step by Step Calculation Workflow
- Convert each percent value to decimal form. Example, 90% becomes 0.90.
- Compute gut survival: Fg = 1 – Eg.
- Compute hepatic survival: Fh = 1 – Eh.
- Compute first-pass survival: Fg x Fh.
- Compute total oral systemic fraction: Fa x Fg x Fh.
- Multiply by oral dose to estimate mg entering systemic circulation.
Example: Dose 100 mg, Fa 90%, Eg 20%, Eh 50%. Then Fa = 0.90, Fg = 0.80, Fh = 0.50. First-pass survival = 0.80 x 0.50 = 0.40. Systemic oral fraction = 0.90 x 0.80 x 0.50 = 0.36. Systemic amount = 100 x 0.36 = 36 mg.
Why This Matters Clinically
A high first-pass effect can make oral therapy inefficient or highly variable. This can affect therapeutic success and safety in several ways. If a drug has high hepatic extraction, changes in liver blood flow can shift exposure. If intestinal metabolism is dominant, coadministered inhibitors or inducers of CYP3A in the gut can dramatically alter concentrations. If absorption is incomplete, formulation changes and food effects can be critical.
- Drugs with large first-pass loss often require higher oral doses than intravenous doses.
- Alternative routes like sublingual, transdermal, or parenteral may bypass parts of first-pass metabolism.
- Interpatient differences in enzyme activity can produce major dose response variability.
- In hepatic impairment, extraction and clearance may change, requiring careful adjustment.
Comparison Table: Oral Bioavailability and First-Pass Burden in Common Drugs
| Drug | Typical Oral Bioavailability (F) | Clinical Interpretation | Approximate First-Pass Burden |
|---|---|---|---|
| Propranolol | About 25% | High first-pass extraction, oral dose much higher than IV equivalent effect | Roughly 75% presystemic loss |
| Morphine | About 20% to 40% | Substantial first-pass metabolism, variable oral exposure | About 60% to 80% presystemic loss |
| Verapamil | About 20% to 35% | Marked first-pass effect contributes to dosing complexity | About 65% to 80% presystemic loss |
| Metoprolol | About 50% | Moderate first-pass metabolism | About 50% presystemic loss |
| Nitroglycerin (oral swallow) | Very low, often under 10% | Extensive first-pass effect, reason for sublingual route in acute use | Often above 90% presystemic loss |
Values are rounded clinical ranges from prescribing literature and pharmacology references. Exact values differ by formulation, patient population, and study design.
Extraction Ratios and Practical Interpretation
| Extraction Ratio Range | Category | Expected Escape Fraction | Practical Impact |
|---|---|---|---|
| 0.00 to 0.30 | Low extraction | 0.70 to 1.00 survives that organ | Less sensitive to flow changes, may still be sensitive to enzyme inhibition if capacity limited |
| 0.30 to 0.70 | Intermediate extraction | 0.30 to 0.70 survives that organ | Mixed behavior, both blood flow and intrinsic clearance can influence exposure |
| 0.70 to 1.00 | High extraction | 0.00 to 0.30 survives that organ | Strong first-pass loss, oral route may need large doses or alternative administration strategy |
Data Inputs You Should Verify Before Calculating
A reliable first-pass calculation is only as good as the assumptions behind your inputs. Clinical data often reports total oral bioavailability F but may not separately report Fa, Fg, and Fh. In early development, these components may be estimated from preclinical models or specialized human studies. In routine practice, you may need to infer components from available evidence.
- Fa uncertainty: Fa can vary with food, pH, motility, solubility, and permeability.
- Fg uncertainty: Intestinal CYP3A and transporter activity differs among individuals and along intestinal segments.
- Fh uncertainty: Hepatic extraction depends on enzyme activity, hepatic blood flow, and protein binding context.
- Study design effects: Reported values differ between healthy volunteer and patient populations.
- Formulation effects: Immediate release vs extended release can change apparent first-pass patterns.
Common Mistakes to Avoid
- Using percentages directly without converting to decimals.
- Adding extraction terms instead of multiplying survival terms.
- Assuming Fa equals 1.0 for all oral drugs.
- Confusing clearance with extraction ratio.
- Ignoring interaction effects like CYP inhibition or induction.
Authoritative Resources for Deeper Study
If you want rigorous background and official reference content, these sources are excellent:
- U.S. Food and Drug Administration (FDA): Clinical Pharmacology and Biopharmaceutics
- NCBI Bookshelf (NIH): Pharmacokinetics overview and principles
- University of Michigan (edu): Open educational pharmacology resources
How to Use This Calculator for Clinical Reasoning
The tool above is designed to make the math transparent. Enter dose, absorption fraction, and extraction ratios. The output reports three things that are directly useful in interpretation:
- Fraction surviving first-pass metabolism which is Fg x Fh.
- Total oral systemic fraction which is Fa x Fg x Fh.
- Estimated systemic mg exposure from dose for a quick sense of delivered amount.
You will also see a chart breaking the oral dose into four components: unabsorbed amount, gut loss, hepatic loss, and systemic amount. This visual decomposition helps you identify where the largest loss occurs and what intervention might improve exposure. For example, if unabsorbed fraction dominates, formulation and absorption strategies matter more than enzyme inhibition. If gut wall extraction dominates, intestinal CYP or transporter interactions become central. If hepatic extraction dominates, liver disease and blood flow effects are more relevant.
Bottom Line
Calculating the fraction of drug surviving first-pass effect is straightforward once you structure the problem correctly. Use survival fractions rather than elimination percentages, multiply each step, and keep Fa conceptually separate from presystemic extraction. With this method, you can move from abstract pharmacokinetics to practical predictions about dose effectiveness, route choice, and patient variability.